CUTISS opens subsidiary in France and receives French government funding

25-01-2022 – The Wyss Zurich project denovoSkin and its startup CUTISS will open a subsidiary, CUTISS Innovation, in Europe’s leading technology park in France.

25 01 2022 press release denovoskin subsidiary sophia antipolis nice

The subsidiary will support and extend the research and development activities of CUTISS, focusing on the development of innovative breakthroughs and products in the field of skin pigmentation restoration and the automation of personalized regenerative medicine. Moreover, CUTISS has also secured its first grant of EUR 300,000 from the Provence-Alpes-Côte d’Azur region that will be used to set up and launch the research laboratory.

Read more

Similar News

Wysszurich keyvisual denovoskin

CUTISS starts onsite denovoSkin™ production and successfully exits Wyss Zurich accelerator

After five years, the project denovoSkin successfully exits the Wyss Zurich Translational Center. With the transfer of technology from the Wyss Zurich Regenerative Medicine Technologies Platform...

Lukas Langenegger with the HemoDevice

hemotune raises CHF 7.25 million Series B1 funding

hemotune announced the closing of a CHF 7.25 million Series B1 for the development of HemoSystem, a breakthrough blood purification platform based on nanoengineered magnetic beads.

Roland Siegwart, Hansjörg Wyss und Simon P. Hoerstrup

Wyss Zurich receives further donation of around CHF 100 million

Having funded more than 20 projects, some of which have already been successfully brought to market, Wyss Zurich has established itself in Zurich, a center of innovation.

Press Release